Details of the Drug Reposition

General Information of This Drug (ID: DMRC0EQ)

Drug Name
Bertilimumab   DMRC0EQ
Synonyms CAT-213; ICo-008
Drug Type
Monoclonal antibody
Structure 3D Structure is Not Available
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ocular allergy DIS38BN3 4A81 Phase 2 [1]
Ulcerative colitis DIS8K27O DD71 Phase 2 [2]
Psoriasis vulgaris DIS6M7AN EA90 Phase 2 [2]
Bullous pemphigoid DISOJLKV EB41.0 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)